Investing NewsBristol Myers Squibb Buys RayzeBio, Its Second Multibillion-Dollar Deal in DaysDecember 26, 2023 by admin 0 Comments Bristol Myers Squibb announced it was buying RayzeBio for $4.1 billion, its second multibillion- dollar acquisition in less than a week. Articles You May Like Learn How to Profit From Elon Musk’s $18 Billion AI Project Stock Market Crash Warning: Don’t Get Caught Holding These 3 Quantum Computing Stocks Shhh! 3 Secret IoT Stocks Flying Below Wall Street’s Radar Tesla Stock’s Rebound Riddle: Navigating the Hype and Headwinds Profit from the Panic: 3 Stocks to Pounce on When They Become Steals